| 232.19 Real-Time Quote |  +0.86 / +0.37%Today’s Change | 126.39 Today|||52-Week Range 238.83 | +58.63% Year-to-Date |
| Additional Patent for Acorda's Ampyra - Analyst Blog 3:20pm / Zacks.com | AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com |
| This Is Incredibly Bullish Behavior 2:02pm / TheStreet.com | Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard May 15 / TheStreet.com |
| Biogen Idec Stock Hits New 52-Week High (BIIB) 10:50am / TheStreet.com | Isis Gets $3.5M Milestone Payment - Analyst Blog May 14 / Zacks.com |
| Positive Data on Novo Nordisk's N9-GP - Analyst Blog May 21 / Zacks.com | Elan seeks to weaken hostile bid with $1bn Theravance deal May 13 / FT.com |
| Biogen's Hemophilia BLA Accepted - Analyst Blog May 20 / Zacks.com | Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog May 08 / Zacks.com |
| Previous close | 231.33 |
| Today’s open | 232.27 |
| Day’s range | 230.06 - 238.83 |
| Volume | 1,148,818 |
| Average volume (3 months) | 1,371,310 |
| Market cap | $54.9B |
| Dividend yield | -- |
| Earnings growth (last year) | +14.29% |
| Earnings growth (this year) | +23.19% |
| Earnings growth (next 5 years) | +17.80% |
| Revenue growth (last year) | +7.78% |
| P/E ratio | 36.8 |
| Price/Sales | 6.35 |
| Price/Book | 7.86 |
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | -0.99 | -1.36% |
| AMGNAmgen Inc | -0.24 | -0.23% |
| GILDGilead Sciences Inc | -0.69 | -1.22% |
| LIFELife Technologies Co... | +0.34 | +0.46% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.91 |
| Annual revenue (last year) | $5.5B |
| Annual profit (last year) | $1.4B |
| Net profit margin | 25.18% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director George A. Scangos, PhD |
Chief Financial Officer & Executive Vice President Paul J. Clancy, MBA |
Corporate headquarters Weston, Massachusetts |
.
